Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Stauss

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|January 10, 2003
Prospects for immunotherapy of malignant diseaseE C Morris, G M Bendle, H J Stauss
European Journal of Immunology|December 1, 1989
The alpha 3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulationN L Samberg, E C Scarlett, H J Stauss
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
A synthetic peptide derived from the tumor-associated protein mdm2 can stimulate autoreactive, high avidity cytotoxic T lymphocytes that recognize naturally processed proteinA M Dahl, P C Beverley, H J Stauss
Journal of Immunogenetics|April 1, 1986
A novel MHC class I molecule as a tumour-specific antigen. Correlation between the antibody-defined and the CTL-defined target structureC Philipps, H J Stauss, R D Wortzel, et al.
European Journal of Immunology|September 1, 1994
Unconventional cytotoxic T lymphocyte recognition of synthetic peptides corresponding to residues 1-23 of Ras proteinL Yin, C Thomas, J J Hsuan, et al.
International Immunology|January 7, 1998
Specificity of CD8+ T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosisX Zhu, H J Stauss, J Ivanyi, et al.
Haematology and Blood Transfusion|January 1, 1987
Identification of a gene encoding a tumor-specific antigen that causes tumor rejectionH J Stauss, M A Fink, B Starr, et al.
European Journal of Immunology|March 4, 1998
Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I moleculesE Sadovnikova, L A Jopling, K S Soo, et al.
Symposium on Fundamental Cancer Research|January 1, 1986
The complexity of unique tumor-specific antigensR D Wortzel, H J Stauss, C Van Waes, et al.
Annual Review of Immunology|January 1, 1988
Unique tumor-specific antigensH Schreiber, P L Ward, D A Rowley, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|January 10, 2003
Prospects for immunotherapy of malignant diseaseE C Morris, G M Bendle, H J Stauss
European Journal of Immunology|December 1, 1989
The alpha 3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulationN L Samberg, E C Scarlett, H J Stauss
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
A synthetic peptide derived from the tumor-associated protein mdm2 can stimulate autoreactive, high avidity cytotoxic T lymphocytes that recognize naturally processed proteinA M Dahl, P C Beverley, H J Stauss
Journal of Immunogenetics|April 1, 1986
A novel MHC class I molecule as a tumour-specific antigen. Correlation between the antibody-defined and the CTL-defined target structureC Philipps, H J Stauss, R D Wortzel, et al.
European Journal of Immunology|September 1, 1994
Unconventional cytotoxic T lymphocyte recognition of synthetic peptides corresponding to residues 1-23 of Ras proteinL Yin, C Thomas, J J Hsuan, et al.
International Immunology|January 7, 1998
Specificity of CD8+ T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosisX Zhu, H J Stauss, J Ivanyi, et al.
Haematology and Blood Transfusion|January 1, 1987
Identification of a gene encoding a tumor-specific antigen that causes tumor rejectionH J Stauss, M A Fink, B Starr, et al.
European Journal of Immunology|March 4, 1998
Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I moleculesE Sadovnikova, L A Jopling, K S Soo, et al.
Symposium on Fundamental Cancer Research|January 1, 1986
The complexity of unique tumor-specific antigensR D Wortzel, H J Stauss, C Van Waes, et al.
Annual Review of Immunology|January 1, 1988
Unique tumor-specific antigensH Schreiber, P L Ward, D A Rowley, et al.
Pageof 5